DEXTRAMERIZATION Trademark

Trademark Overview


On Wednesday, April 6, 2022, a trademark application was filed for DEXTRAMERIZATION with the United States Patent and Trademark Office. The USPTO has given the DEXTRAMERIZATION trademark a serial number of 79347601. The federal status of this trademark filing is REGISTERED as of Tuesday, October 17, 2023. This trademark is owned by Immudex ApS. The DEXTRAMERIZATION trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and technological services, namely, scientific research, analysis and testing in the fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; scientific research; scientific research services, namely, diagnostic services related to research; analysis of medicine, pharmaceuticals and vaccines of others to assure compliance with industry standards; industrial research services in the fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; basic scientific research and clinical scientific research, hereunder for medicine and vaccine development; product research and development in the field of diagnostic preparations; scientific analysis services in fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; scientific laboratory services; quality control testing and consultancy related thereto; scientific research, testing and analysis services in the fields...
dextramerization

General Information


Serial Number79347601
Word MarkDEXTRAMERIZATION
Filing DateWednesday, April 6, 2022
Status700 - REGISTERED
Status DateTuesday, October 17, 2023
Registration Number7191552
Registration DateTuesday, October 17, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 1, 2023

Trademark Statements


Goods and ServicesScientific and technological services, namely, scientific research, analysis and testing in the fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; scientific research; scientific research services, namely, diagnostic services related to research; analysis of medicine, pharmaceuticals and vaccines of others to assure compliance with industry standards; industrial research services in the fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; basic scientific research and clinical scientific research, hereunder for medicine and vaccine development; product research and development in the field of diagnostic preparations; scientific analysis services in fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; scientific laboratory services; quality control testing and consultancy related thereto; scientific research, testing and analysis services in the fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; providing scientific technology and methods to others, namely, rental of laboratory apparatus and instruments and scientific research consulting; providing scientific information about industrial analysis and research services in the fields of medicine, pharmaceuticals, the immune system, medical diagnostic analysis and vaccines; development of scientific, chemical and medical products for others for medical and research purposes; development of scientific, chemical and medical products for others in the fields of biochemistry and biotechnology; providing scientific information, advice and consultancy to others in the fields of biochemistry and biotechnology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, June 23, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmudex ApS
Party Type30 - Original Registrant
Legal Entity Type24 - NOT AVAILABLE
AddressDK

Party NameImmudex ApS
Party Type20 - Owner at Publication
Legal Entity Type24 - NOT AVAILABLE
AddressDK

Party NameImmudex ApS
Party Type10 - Original Applicant
Legal Entity Type24 - NOT AVAILABLE
AddressDK

Trademark Events


Event DateEvent Description
Wednesday, February 14, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 19, 2024FINAL DISPOSITION NOTICE SENT TO IB
Friday, January 19, 2024FINAL DISPOSITION PROCESSED
Wednesday, January 17, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 17, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 17, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 1, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 1, 2023PUBLISHED FOR OPPOSITION
Wednesday, July 12, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 23, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 23, 2023EXAMINER'S AMENDMENT ENTERED
Friday, June 23, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, June 23, 2023EXAMINERS AMENDMENT E-MAILED
Friday, June 23, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 21, 2023ASSIGNED TO EXAMINER
Wednesday, May 3, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, April 2, 2023NEW REPRESENTATIVE AT IB RECEIVED
Monday, November 21, 2022REFUSAL PROCESSED BY IB
Friday, October 28, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, October 28, 2022REFUSAL PROCESSED BY MPU
Saturday, September 3, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, September 2, 2022NON-FINAL ACTION WRITTEN
Wednesday, August 24, 2022ASSIGNED TO EXAMINER
Tuesday, August 23, 2022APPLICATION FILING RECEIPT MAILED
Friday, August 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 18, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB